QRH-882260 Heptapeptide

DRUG2 trials

Sponsors

Danielle Kim Turgeon, D. Kim Turgeon, MD

Conditions

CholangiocarcinomaColon Cancer Prevention

Phase 1

Study of QRH-882260 Heptapeptide Application in the Colon

TerminatedNCT03148119

Danielle Kim TurgeonColon Cancer Prevention

Start: 2017-03-31End: 2017-07-11Updated: 2018-04-24

Fluorescence QRH-882260 Peptide Imaging in the Bile Duct

CompletedNCT03438435

D. Kim Turgeon, MDCholangiocarcinoma

Start: 2019-04-22End: 2020-08-21Updated: 2020-12-02